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Introduction: Mesenchymal stem cells (MSCs) are multipotent and have been derived from various tissues.
Although MSCs share many basic features, they often display subtle tissue specific differences. We previously
demonstrated that bone marrow (BM) MSCs frequently become polyploid in culture. This tendency was mediated
by a reduction in the expression of H19 long non-coding RNA during the transition from a diploid to a polyploid
state.
Methods: MSCs were derived from both BM and adipose tissue of mice and expanded under normoxic and
hypoxic culture conditions. Cells were stained by propidium iodide and their ploidy was evaluated by FACS. Gene
expression of independent MSC preparations was compared by quantitative real time PCR and protein expression
levels by Western blot analysis. p53 silencing in MSCs was performed by a specific small hairpin RNA (shRNA).
Results: We set to examine whether genomic instability is common to MSCs originating from different tissues. It is
demonstrated that adipose derived MSCs (ASCs) tend to remain diploid during culture while a vast majority of BM
MSCs become polyploid. The diploid phenotype of ASCs is correlated with reduced H19 expression compared to
BM MSCs. Under hypoxic conditions (3% oxygen) both ASCs and BM MSCs demonstrate increased RNA expression
of H19 and Vascular endothelial growth factor A. Importantly, ASC gene expression is significantly less variable than
BM MSCs under both oxygen conditions, indicating to their superior homogeneity. Gene expression analysis
revealed that p53 target genes, often induced by DNA damage, are up-regulated in ASCs under basal conditions.
However, p53 activation following treatment with DNA damaging agents was strongly elevated in BM MSCs
compared to ASCs. We found that p53 is involved in maintaining the stable diploid state of ASCs as p53 shRNA
induced ploidy changes in ASCs but not in BM MSCs.
Conclusions: The increased genomic stability of murine ASCs together with their lower H19 expression and relative
homogeneity suggest a tissue specific higher stability of ASCs compared to BM MSCs, possibly due to higher
activity of p53. The tissue specific differences between MSCs from a different tissue source may have important
consequences on the use of various MSCs both in vitro and in vivo.* Correspondence: nirs@tlvmc.gov.il
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The ability of mesenchymal cells to propagate under tissue
culture conditions has been studied since the 1960s. Ini-
tially, the capacity of bone marrow (BM)-derived mesen-
chymal stromal cells to regenerate bone and the BM
microenvironment in vivo was demonstrated [1]. Mesen-
chymal cells were then also derived from the stromal vas-
cular fractions of fat tissue and termed preadipocytes [2,3].
Cultured mesenchymal cells were later termed mesenchy-
mal stem cells (MSCs) to denote their multipotent differ-
entiation potential, and the use of these cells for
regenerative medicine was suggested [4]. Since their iden-
tification, multipotent MSCs were isolated from most
adult tissues, cord blood and placenta [5]. MSCs usually
express a series of cell surface markers [6]. However, their
definition lies mainly upon their multipotent nature, adhe-
siveness and morphology [6,7]. Although MSCs from dif-
ferent organs share many common features, they may also
harbor tissue-specific functions. Characterization of the
tissue-specific properties of MSCs may assist the under-
standing of their physiological functions.
Human MSCs have a relatively stable genome at early
passages, but may acquire chromosomal aberrations dur-
ing extended culture [8,9] and tend to undergo senescence
preventing their long-term propagation [9]. Gaining better
understanding of the mechanisms that govern genomic
stability of MSCs during passaging may allow one to de-
fine improved culture conditions that will prevent these
events and the tumorigenic transformation of the MSCs.
We previously demonstrated that the majority of murine
BM MSCs become polyploid in the early stages of their
expansion in culture and that the noncoding RNA H19
plays a major part in these events and predicts their corre-
sponding tumor-forming capacity [10].
Here we show that, unlike BM MSCs, MSCs from adi-
pose tissue origin retain their normal diploid state dur-
ing culture. This tendency is accompanied by a reduced
H19 expression compared with similar cells from the
BM, further suggesting that a restrained H19 expression
preserves the normal diploid state. Importantly, adipose-
derived mesenchymal stem cells (ASCs) that were pre-
pared from independent mice also demonstrated a
significantly more homogeneous expression phenotype
of multiple genes compared with BM MSCs under both
normal and stress culture conditions. A partial explan-
ation for the higher stability of ASCs may be provided
by their increased basal activation of the p53 signaling




MSCs were derived from the BM of C57Bl mice (Harlan,
Jerusalem, Israel). BM MSCs were flushed from femurs andtibias using murine MesenCult Basal Media and supple-
ment (Stem Cell Technologies, Vancouver, Canada). ASCs
were isolated from the mice intra-abdominal fat tissue
using 0.1% collagenase (Sigma, Rehovot, Israel) and were
separated from fat by centrifugation. Both isolates were
expanded under tissue culture conditions as detailed below.
To examine the effect of different cell culture media on
the ploidy of ASCs, the cells were cultured either in ADSC
Basal Media and supplement (Lonza, Walkersville, MD,
USA), murine MesenCult Basal Media and supplement
(Stem Cell Technologies) or Dulbecco’s modified Eagle’s
medium high glucose with 10% fetal calf serum, 60 μg/ml
penicillin and 100 μg/ml streptomycin as stated. For com-
parison of BM and ASCs from the same mouse donor, all
cells were cultured in murine MesenCult Basal Media and
supplement; the purity and cell number were high enough
to be used experimentally for ASCs at passage 4 while BM
MSCs were ready for first derivation at passage 7 or
higher.
For hypoxia, cells were cultured in 37°C with 10% carbon
dioxide in a Thermo Scientific Forma incubator (Thermo
Scientific, Waltham, MA USA) monitored to 3% oxygen
from the moment of isolation.
The Weizmann and Tel Aviv Medical Center Institu-
tional Animal Care and Use Committee approved all
animal experiments.
Differentiation
For adipogenesis, confluent cultured cells in a 24-well
plate received adipogenic medium containing 10 μg/ml
insulin (Sigma), 1 × 10–6 M dexamethasone (Sigma) and
0.5 mM IBMX (Sigma). ASC adiopogenic medium con-
tained also 50 μM indomethacin (Sigma). The cells were
grown for 3 weeks, with medium replacement twice a
week. Adipogenesis was detected by Oil red O staining.
For osteogenesis, confluent cultured BM MSC cells in a
24-well plate received osteogenic medium containing
50 μg/ml L-ascorbic acid-2 phosphate, 10 mM glycerol 2-
phosphate disodium salt, and 1 × 10–8 M dexamethasone
(all from Sigma). For osteogenesis, confluent ASCs were
cultured in the StemPro® Osteogenesis Differentiation Kit
(Gibco, Grand Island, NY, USA). The cells were grown for
3 weeks with medium replacement twice a week. Osteo-
genic differentiation was detected by Alizarin red staining.
Photographs were taken using an Olympus IX71 micro-
scope equipped with a DP51 camera (Olympus, Tokyo,
Japan).
Flow cytometry
For surface marker analysis, MSCs were harvested and in-
cubated with specific phycoerythrin (PE)-labeled antibodies
for 1 hour. Antibodies anti-CD11b–PE, anti-CD45.2–PE,
anti-CD31–PE, anti–Ter-119–PE and anti-CD34-PE, rat
IgG2b isotype control–PE and rat and mouse IgG2a
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(eBioscience, San Diego, California, USA), anti–SCA-1–PE
was purchased from PharMingen (San Diego, California,
USA), and anti–CD34–PE was purchased from Santa Cruz
(Santa Cruz, Dallas, Texas, USA). Cells were analyzed
using the LSRII flow cytometer (Becton, Dickinson, New
Jersey, USA).
For DNA content estimation, cells were fixed with 70%
ethanol/phosphate-buffered saline, treated with RNaseA
0.4 mg/ml (Sigma), and stained with propidium iodide
0.1 mg/ml (Sigma). Labeled cells were analyzed using a
FACScan flow cytometer (Becton Dickinson Immunocyto-
metry Systems). Fresh splenocytes were used as control
diploid cells.
Chromosome count
Chromosome spreads were prepared from all cells at pas-
sage 7 or higher, treated with KCl (0.075 M) and fixed
using methanol/acetic acid (3:1), and were then stained
with 4′,6-diamidino-2-phenylindole and visualized using a
Zeiss Axio Imager Z1 microscope (Carl Zeiss Microscopy,
Göttingen, Germany). Chromosomes from at least 10
metaphases were counted from each cell preparation.
Ultraviolet irradiation
BM MSCs or ASCs (200,000 cells) from similar passages
were plated in 6 cm plates. The next day, cells were irra-
diated at UV-C (254 nm) using a low-pressure mercury
lamp (TUV 15w G15T8; Philips, Andover, MA, USA).
After 24 hours, cells were taken for RNA analysis.
Oxidative stress
Oxidative stress was induced by adding hydrogen perox-
ide (H2O2; Sigma) for 1 hour at a concentration of
100 μM. RNA extraction was performed 6 hours after
the H2O2 treatment.
DNA double-strand break induction
DNA double-strand breaks were induced by incubating
the cells in 0.5 μg/ml doxorubicin (Sigma) for 24 hours.
At the end of the 24-hour incubation, cells were washed
and RNA was extracted.
p53 knockdown
p53 knockdown experiments were carried out in the
laboratory of Prof. Varda Rotter, (Weizmann Institute of
Science, Rehovot, Israel). The p53 short hairpin RNA
vector and its human Rb short hairpin RNA control vector
were kindly provided by Dr SW Lowe (Cold Spring
Harbor Laboratory, Cold Spring Harbor, NY, USA). Eco-
tropic Phoenix-packaging cells were transfected with
10 μg DNA of the appropriate retroviral construct by a
standard calcium phosphate procedure. Culture superna-
tants were collected 36 to 48 hours after transfection andfiltered. BM MSCs and ASCs were infected with the
filtered viral supernatants in the presence of 4 μg/ml poly-
brene (Sigma) for 12 hours, after which the medium was
changed. Fresh viral suspensions were added after a 24-
hour interval for an additional 12 hours. RNA was ex-
tracted from the cells to verify p53 knockdown. The cells
were expanded for an additional three passages and then
taken for ploidy analysis.
Western blot
For immunoblotting, proteins were separated by SDS–
PAGE, transferred to a nitrocellulose membrane and de-
tected with the anti-p53 antibody (Santa Cruz) or primary
antibody or an anti-glyceraldehyde-3-phosphate dehydro-
genase (Sigma) and horseradish peroxidase-conjugated
secondary antibody using enhanced chemiluminescence
western blotting reagents (Thermo Scientific) and film
(Fujifilm, Tokyo, Japan). Densitometry was conducted
using ImageJ software ().
Quantitative real-time PCR
RNA from passage 4 ASCs and passage 7 or higher BM
MSCs was extracted using the NucleoSpin RNA II kit
(Macherey-Nagel, Düren, Germany), and cDNA was pre-
pared using M-MLV Reverse Transcriptase (Promega,
Madison, WI, USA) according to the manufacturer’s pro-
tocols. Real-time PCR was carried out using the perfeCTa
SYBR mix (Quanta BioSciences, Gaithersburg, MD, USA)
and processed using Step One Plus (Applied Biosystems
Foster, CA, USA) with normalization to HPRT or 18S.
The real-time primers used are as follows: Hif1α, 5′-
ACAAGTCACCACAGGACAG-3′ and 5′-AGGGAGAA
AATCAAGTCG-3′ [11]; VEGFa, 5′-GCGGATCAAAC
CTCACCAAA-3′ and 5′-TTCACATCTGCTGTGCTG
TAGGA-3′ [12]; H19, 5′-GCTAGGGTTGGAGAGGA
ATGG-3′ and 5′-AAAAGTAACCGGGATGAATGTCT
G-3′ [10]; p53, 5′-AGAGTATTTCACCCTCAAGATC
















p16, 5′-TTGGGCGGGCACTGAATCTC-3′ and 5′-AGT
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CCCCAAAATGG-3′ and 5′-GGTCCTTTTCACCAGC
AAGCT-3′; and Rn18s, 5′-CGAAAGCATTTGCCAAGA
AT-3′ and 5′-AGTCGGCATCGTTTATGGTC-3′.
Statistical analysis
Statistical analysis was done using R statistical software
and SigmaPlot, v.11 (SigmaPlot, v.11 (Systat Software, San
Jose, CA)). P <0.05 was considered statistically significant
using the Mann–Whitney test or t test as stated. The F-
variance test was used to compare the variance of two
groups, P <0.05 showing statistical difference.
Results and discussion
Unlike BM MSCs, ASCs retain their diploid state under
various culture conditions
We have reported previously that mouse BM MSCs fre-
quently become polyploid during culture [10] and wanted
to determine whether this tendency is common also to
ASCs. All ASC preparations (ASC adipogenic and osteo-
genic differentiation and surface marker expression charac-
teristics are demonstrated in Figure 1A,B, respectively),
regardless of the culture conditions used, were diploid at
early passages (passages 3 to 4) and only one out of the five
preparations became tetraploid at a later passage (passages
7 to 9) (Figure 1C). Isolates of paired BM MSCs and ASCs
(both derived from the same mouse) were extracted from
several independent mice (BM MSC adipogenic and osteo-
genic differentiation and surface marker expression charac-
teristics are presented in Additional file 1). Figure 2A,B
shows an overlay of the DNA content of MSC preparations
from paired adipose or BM tissue. While the vast majority
of ASCs were diploid, most BM MSCs were polyploid with
varying amounts of DNA content. The DNA content deter-
mination by flow cytometry was confirmed by a chromo-
some spread analysis, and the median of chromosome
number of ASCs and BM MSCs verified their diploid and
tetraploid state respectively (Figure 2C,D). ASCs thus dem-
onstrate relative genomic stability under various conditions
and in a sex-independent manner.
It was previously reported that MSCs expanded under
hypoxic conditions (1 to 5% oxygen) are superior in their
culture expansion, differentiation, and genomic stability
compared with MSCs that were grown under normoxic
conditions (atmospheric oxygen level) and are therefore
more suitable for clinical use [13-15]. Figure 3A,B shows an
overlay of the DNA content of MSC preparations from
paired adipose or BM tissue grown under hypoxic condi-
tions. ASCs grown under hypoxic conditions showed a dip-
loid phenotype while BM MSC preparations demonstrated
a polyploid phenotype. Thus, culturing BM MSCs under
hypoxic conditions did not significantly inhibit the transi-
tion of BM MSCs to a polyploidy state. Altogether, 76% (13
out of 17 cell preparations) of mouse BM MSCpreparations, regardless of culture conditions, demon-
strated a polyploid phenotype compared with only 9% poly-
ploidy (three out of 32 cell preparations) of ASCs
(Figure 3C).ASCs ability to retain a diploid state is accompanied by
reduced H19 expression
Our previous findings demonstrated that rare diploid
BM MSC populations express far higher levels of H19
RNA as compared with polyploid BM MSC and are
more tumorigenic [10]. Since most BM MSCs became
polyploid, we assumed that the high H19 expression in
diploid BM MSCs promotes their instability. It was thus
hypothesized that genomic stability would correlate with
lower levels of H19. Evaluation of the H19 expression
demonstrated that its mean expression in ASCs under
normoxic conditions was 43-fold lower than in polyploid
BM MSCs, indicating a more stable state of these cells
in culture (Figure 3D and Table 1). As shown previously,
the H19-IGF2 locus is epigenetically controlled and is
important for stem cell function [16]. Our results indi-
cate that there might be a difference in the epigenetic
control of H19 expression between ASCs and BM MSCs,
as suggested by our RNA expression analysis. Such a dif-
ference might reveal additional inconsistencies in the
properties of the two cell types, possibly through mir675
expression (which is derived from H19). As the receptor
for IGF2, IGF1r, is regulated by mir675, it would be of
interest to examine IGF2 signaling in these cells. Future
studies characterizing the differentially methylated re-
gion of the H19-IGF2 locus in ASCs and BM MSCs are
thus required in order to obtain a more broad descrip-
tion of their different properties.ASCs response to different oxygen conditions is more
homogeneous than that of BM MSCs
H19 expression and vascular endothelial growth factor A
expression were shown previously to increase under hyp-
oxic conditions in a hypoxia-inducible factor 1α-dependent
manner [17-19]. This was therefore used to compare the re-
sponses of BM MSCs and ASCs to different oxygen levels.
We found a significant increase in H19 and vascular endo-
thelial growth factor A expression, seen in both ASCs and
BMMSCs grown under hypoxic conditions (Figure 3D,F re-
spectively and Table 1). A previous report stated that H19 is
elevated in hypoxia only in p53 mutant or null settings [19].
Hypoxia-inducible factor 1α mRNA expression remained
unchanged under both oxygen conditions (Figure 3E), most
probably since its protein levels are increased mainly due to
hypoxia-induced stabilization, rather than to increased tran-
scription [17,18]. Interestingly, H19 mean expression in
ASCs under hypoxic conditions was 59-fold lower than in
polyploid BM MSCs, indicating again a more stable state of
Figure 1 (See legend on next page.)
Ravid et al. Stem Cell Research & Therapy 2014, 5:139 Page 5 of 11
http://stemcellres.com/content/5/6/139
(See figure on previous page.)
Figure 1 Adipose-derived mesenchymal stem cells remain diploid under various culture conditions. Adipose-derived mesenchymal
stem cells (ASCs) were characterized according to (A) their differentiation potential and (B) their surface marker expression (percentage reflects
cell-staining above background). (C) Five adipose-derived mesenchymal stem cell preparations were grown in different growth media (as indicated: two
preparations in Mesencult medium, two preparations in ADSC medium and one preparation in Dulbecco’s modified Eagle’s medium (DMEM)) and their
DNA content was analyzed by flow cytometry at early and late passages, diploid (2N) and tetraploid (4N). Primary diploid spleen cells used as control.
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diploid state during passaging (Figure 1C).
Although the change in RNA expression under different
oxygen levels showed a similar trend in both ASCs and BM
MSCs (Figure 3D,E,F), the variation in expression was signifi-
cantly lower in ASCs compared with BM MSCs, as evident
from the P (variance) analysis (Table 1), indicating a more
homogeneous nature of ASC-independent preparations.
ASCs ability to retain a diploid state is accompanied by a
higher basal activity of p53, as indicated by the higher
expression of its downstream targets
Normal cells expressing wildtype p53 were demonstrated
previously to arrest in the G1 phase subsequent to theFigure 2 Cultured adipose-derived mesenchymal stem cells retain the
cells that become polyploid. Independent preparations of paired (A) adip
mesenchymal stem cells (BM MSCs; prepared from the same male or fema
analyzed by flow cytometry, diploid (2N) and tetraploid (4N). Resulting plots fr
single graph; six female and six male adipose-derived mesenchymal stem cell
spreads were made from three adipose-derived mesenchymal stem cells and
(straight short line) chromosome count is shown (10 to 15 different metaphas
diploid or tetraploid DNA contents at chromosome numbers 40 and 80, respe
chromosomes from a single preparation of adipose-derived mesenchymal steinduction of tetraploidy. p53 is thus considered to be a
guardian of genomic stability that prevents the develop-
ment of polyploidy in normal cells [20,21]. Our findings
repeatedly show that tetraploid BM MSCs continue to ex-
pand and do not undergo a growth arrest although they
express wildtype p53 (the wildtype RNA sequence of p53
in tetraploid BM MSCs was examined and verified) (data
not shown). A comparison of the RNA expression levels
of p53 between BM MSCs and ASCs showed no signifi-
cant difference (Figure 4A). Consistent with our previous
RNA assessments, however, the p53 expression profile
was significantly less variable between ASC preparations
compared with BM MSC preparations. Similarly to the
RNA expression analysis, only a slight increase in p53ir diploid state, in contrast to bone marrow mesenchymal stem
ose-derived mesenchymal stem cells (ASCs) and (B) bone marrow
le mouse), were expanded in Mesencult and their DNA content was
om male/female ASCs/BM MSCs were overlaid and are presented in a
s and six female and five male BM MSCs were used. (C) Chromosome
three BM MSC preparations and a graphic summary of the median
es were counted from each cell preparation). Horizontal dashed lines,
ctively. (D) Examples of the 4',6-diamidino-2-phenylindole-stained
m cells and BM MSCs as summarized in the previous section.
Figure 3 Independent adipose-derived mesenchymal stem cell preparations retain their diploid state under hypoxia and react
homogeneously to changing oxygen conditions. Independent preparations of paired (A) adipose-derived mesenchymal stem cells (ASCs)
and (B) bone marrow mesenchymal stem cells (BM MSCs; prepared from the same male or female mouse) were expanded in Mesencult under
hypoxic conditions (3% oxygen) and their DNA content was analyzed by flow cytometry. Resulting plots from male/female adipose-derived
mesenchymal stem cells/BM MSCs were overlaid and are presented in a single graph, diploid (2N) and tetraploid (4N); six female and six male
adipose-derived mesenchymal stem cells and six total female and male BM MSCs were used. (C) Graph summarizing the percentage of
adipose-derived mesenchymal stem cells and BM MSCs that became polyploid out of all cell preparations cultured during the study. (D), (E) (F)
Comparison of the RNA level of independently derived adipose-derived mesenchymal stem cells or BM MSCs that were expanded either in
hypoxic (H) or normoxic (N; normal oxygen) conditions made by quantitative real-time PCR. *P <0.05, Mann–Whitney test (each group size is
mentioned in Table 1). HIF1α, hypoxia-inducible factor 1α; VEGFa, vascular endothelial growth factor A.
Table 1 Statistical analysis of RNA expression levels comparing groups of different mesenchymal stem cell
preparations
Mean adipose Mean BM Adipose (n) BM (n) P, Mann–Whitney P, F-variance
Normoxic adipose vs. BM
H19 0.002 0.092 11 11 0.004 0
HIF1α 4.786 5.275 11 11 >0.05 0.0007
VEGFa 2.974 1.647 10 11 0.01 0.01
Hypoxic adipose vs. BM
H19 0.018 0.85 12 6 0.001 0
HIF1 α 5.157 7.078 12 6 >0.05 0.002
VEGFa 6.413 3.227 12 6 0.013 >0.05
Mean normoxia Mean hypoxia Normoxia (n) Hypoxia (n) P, Mann–Whitney
Normoxic vs. hypoxic
H19 BM 0.092 0.85 11 6 0.024
VEGFa BM 1.647 3.227 11 6 0.05
H19 adipose 0.002 0.018 11 12 0.00005
VEGFa adipose 2.974 6.413 10 12 0.00015
Diploid vs. polyploid
H19 diploid adipose 0.002 0.018 11 12
H19 polyploid BM 0.099 1.068 10 3
Polyploid BM/diploid adipose 43.137 59.447
BM, bone marrow; HIF1α, hypoxia-inducible factor 1α; VEGFa, vascular endothelial growth factor A.
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Figure 4 Adipose-derived mesenchymal stem cells have higher levels of DNA damage-related p53 targets, similar levels of Bcl-2 family
p53 targets, and a lower p16 and p19 expression than bone marrow mesenchymal stem cells. Independent nine to 10 preparations
(A, C, D, I, J) or six preparations (B, E, F, G, H) of paired adipose-derived mesenchymal stem cells (ASCs) and bone marrow mesenchymal stem
cells (BM-MSCs; prepared from the same male or female mouse) were analyzed for RNA levels of the indicated gene by quantitative real-time
PCR. *P <0.05, paired two-tailed t test of adipose-derived mesenchymal stem cells vs. BM-MSCs; #P <0.05, F-variance test of adipose-derived
mesenchymal stem cells vs. BM-MSCs.
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observed in ASCs compared with BM MSCs (data not
shown). Being a transcription factor, p53 activity is often
determined by its ability to induce the transcription of
various target genes. Interestingly, the expression levels of
five downstream targets of p53 known to be induced by
DNA damage, Mdm2, p21, btg2, Cycling1, and Mgmt was
higher in ASCs compared with BM MSCs (Figure 4B,C,D,
E,F), indicating a higher basal p53 activity in ASCs. p53
activation in ASCs, however, does not seem to promote
the Bcl-2 apoptotic pathway because no increased expres-
sion of Puma and Bax pro-apoptotic genes was observed
compared with BM MSCs (Figure 4G,H). The lower basal
activity of p53 in BM MSCs provides a possible mechanis-
tic explanation for the continuous propagation of BM
MSCs following their polyploidization. The higher p53 ac-
tivity of ASCs may prevent polyploidization, thereby
allowing them to retain their genomic stability and a dip-
loid state. As suggested for the H19-IGF2 locus, the differ-
ences in p53 activation could be attributed to epigenetic
control in general, and gene imprinting specifically. In fact,
we have previously established a critical role for epigenetic
modulation in the plasticity of BM MSCs [22]. An
example is p57kip2, a paternally imprinted gene, which
was demonstrated to play a role in cell cycle progression
and DNA damage response is well established [23]. Thus,
it would be of interest to examine whether this protein
and its regulation also play a role in the differences ob-
served between ASCs and BM MSCs.Lower expression of p16 and p19 in ASCs compared with
BM MSCs
The p19ARF and p16ink4a proteins are important tumor sup-
pressors [24]. In contrast to p21 and btg2, both p16 and
p19 expression levels were higher in BM MSCs compared
with ASCs (Figure 4I,J). The higher p53 activity of ASCs
suggests a higher stability of p53 in these cells. Activation
of p53 by the p19 pathway occurs through the interaction
of p19 with mdm2, thereby preventing p53 degradation
[25]. The higher expression of p19 combined with the
lower p53 activation in BM MSCs suggests that p53 activa-
tion does not occur in these cells in a p19-dependent man-
ner. This is in accordance with reports suggesting p19
activation and growth arrest in response to oncogene-
induced proliferation and not tetraploidization or DNA
damage [24,26,27]. In agreement with our previous find-
ings, p19 and p16 showed a more heterogeneous expres-
sion in BM MSC preparations compared with ASCs.
Both BM MSCs and ASCs respond normally to DNA damage,
as indicated by an increased expression of p53 targets
Given the difference in p53 activity between ASCs and
BM MSCs under basal culture conditions, we set to
examine the function of the p53 pathway following
ultraviolet-induced DNA damage. Both ASCs and BM
MSCs responded in a dose-dependent manner by elevat-
ing p53 target genes, demonstrating normal functionality
of p53 (Figure 5A,B). The normal p53 DNA damage re-
sponse further suggests that the continued propagation
Figure 5 Adipose-derived mesenchymal stem cells demonstrate milder response to ultraviolet and doxorubicin-induced DNA
damage and to oxidative stress. (A), (B) p21 and btg2 RNA expression after ultraviolet (UV) irradiation in elevating doses (J/m2) in four bone
marrow mesenchymal stem cell (BM MSC) preparations and three adipose-derived mesenchymal stem cell (ASC) preparations. No irradiation was
normalized as 1, bars indicate mean ± standard deviation. Regression of gene expression fold-change as a function of UV intensity was compared
between tissues using analysis of covariance, with tissue as a categorical factor, and UV intensity as a covariate. (C), (D) Induction of RNA
expression of the indicated genes following incubation with either 0.5 μg/ml doxorubicin for 24 hours or 6 hours following incubation with
hydrogen peroxide (H2O2), respectively, was compared between six adipose-derived mesenchymal stem cell and BM MSC preparations. *P <0.05,
unpaired equal variance two-tailed t test of adipose-derived mesenchymal stem cells vs. BM-MSCs.
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wildtype p53. The extent of the response was greater in
BM MSCs compared with ASCs (significantly for btg2 by
regression analysis). To confirm the increased responsive-
ness of BM MSCs to DNA damage signals, we compared
the expression levels of various p53 target genes following
doxorubicin and H2O2 exposure. Similarly to ultraviolet,
exposure to both doxorubicin and H2O2 resulted in greater
induction of eight p53 target genes (p21, Btg2, cycling1,Mgmt, Mdm2, Ercc5, Bax and Puma) in BM MSCs com-
pared with ASCs, confirming the increased responsiveness
of BM MSCs to DNA damage signals (Figure 5C,D). This
indicates that ASCs are less responsive to DNA damage,
possibly because of their higher p53 activation level.
ASCs undergo ploidy shifts following p53 depletion
To examine the role of p53 in maintaining the stable
diploid state of ASCs, we depleted p53 mRNA in ASCs
Figure 6 p53 silencing promotes a ploidy change in adipose-
derived mesenchymal stem cells but not in bone marrow
mesenchymal stem cells. Ploidy and p53 expression were evaluated
in (A) bone marrow mesenchymal stem cells (BM MSCs) and (B)
adipose-derived mesenchymal stem cells (ASCs) following p53 silencing
by a specific p53 short hairpin RNA (shRNA) or a nonrelevant shRNA
control. RNA was extracted 3 days after infection. For ploidy analysis, cells
were expanded for an additional three passages. Con, control;
KD, knockdown.
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Figure 6, p53 depletion induced a clear ploidy change in
ASCs but not in BM MSCs. This, together with the sig-
nificant differences found in the activity of p53 between
ASCs and BM MSCs under basal and perturbed condi-
tions, suggests that p53 is pivotal in maintaining the dip-
loid state of ASCs.
Conclusions
The findings presented in this study clearly demonstrate
the higher stability of murine ASCs compared with BM
MSCs, as reflected in their ability to maintain a diploid
phenotype, together with their uniform nature. Import-
antly, these markedly different phenotypes do not result
from different culture conditions (BM MSCs and ASCs
extracted from the same mouse were grown under the
exact same conditions) but from a signature that most
probably comes from their tissue origin. Consistent with
our previous report that demonstrated H19 as a major
contributor to BM MSC instability and tumorigenic po-
tential, we find here that the increased stability of ASCs
is correlated with their significantly lower H19 expres-
sion compared with BM MSCs. This further suggests
that a restrained H19 expression serves as a stabilizing
parameter in cultured MSCs. In addition to their genomic
stability, ASCs from independent preparations demon-
strated a far more homogeneous expression pattern of mul-
tiple genes under normal and stress conditions compared
with BM MSCs, indicating that their transcription state is
more stable. Interestingly, the superior uniformity and sta-
bility of murine ASCs was also correlated with an increasedbasal p53 activity. The significant difference in p53 activity
between ASCs and BM MSCs was also evident following
DNA damage (ultraviolet irradiation, H2O2 and doxorubi-
cin) in which a significantly more robust induction of p53
target genes was seen in BM MSCs. Knockdown of p53 in
ASCs resulted in significant ploidy changes, confirming its
critical role in maintaining a stable diploid state.
Altogether our results suggest that MSCs isolated from
different tissue sources hold distinct properties, which
are manifested in vitro. This tissue-specific phenotype
may have important bearing on the ability of MSCs to
reach any intended clinical purpose. Further emphasis
should thus be given to elucidating the origin-specific
nature of MSCs.
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